Calamos Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Calamos Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-27,000	Closed	-$2.51M	–	1245
2021 Q4	$2.51M	Buy	+27,000	New	+$1.78M	0.01%	856

Calamos Advisors's ARNA Position: Q1 2022 in Review

Calamos Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 27,000 shares — an estimated $2.51M sold.

Calamos Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $2.51M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Calamos Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Calamos Advisors sold 27,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.51M.
Calamos Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Calamos Advisors's Arena Pharmaceuticals Inc position peaked at $2.51M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.